Stock comparison

GILDvsUTHR

Gilead Sciences IncvsUnited Therapeutics Corp. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

GILD

Gilead Sciences Inc

$130.4

+7.35%

Biotechnology$173.4BNASDAQ

UTHR

United Therapeutics Corp

$572.85

+15.96%

Biotechnology$23.1BNASDAQ

60-day price, rebased to 100

GILD -8.99% · UTHR +22.59%

Round-by-round

GILD 2·UTHR 4

EdgeUTHR

Valuation upside

-25.70% vs -10.40% to DCF fair value

EdgeUTHR

Balance-sheet strength

Altman Z 4.47 vs 20.69

EdgeGILD

Fundamental quality

Piotroski 8.00 vs 7.00 (of 9)

EdgeUTHR

Growth + margins

Rule-of-40 34.50 vs 43.10

EdgeUTHR

60-day momentum

-8.99% vs +22.59% price return

EdgeGILD

Market-cap liquidity

$173.4B vs $23.1B

Verdict

Across6categories,UTHRtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onGILDorUTHR

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.